Related Experiment Video
Updated: Mar 31, 2026

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
siRNA Delivery by Stimuli-Sensitive Nanocarriers.
Giuseppina Salzano, Daniel F Costa, Vladimir P Torchilin1
1Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, 360 Huntington Ave, Boston, MA 02115, USA. v.torchilin@neu.edu.
Stimuli-sensitive nanoparticles offer a promising approach for delivering small interfering RNA (siRNA) therapeutics. These advanced systems target disease sites, improving the potential of gene therapy for various human conditions.
Area of Science:
- Biotechnology
- Nanomedicine
- Gene Therapy
Background:
- Small interfering RNA (siRNA) is a potent tool for treating diseases by modulating gene expression.
- Therapeutic siRNA delivery faces challenges, hindering clinical translation despite preclinical success.
- Stimuli-sensitive nanopreparations are emerging as advanced platforms for targeted gene therapy.
Purpose of the Study:
- To review recent advancements in stimuli-sensitive strategies for siRNA delivery.
- To explore the potential of combining multiple stimuli-responsive elements in nanocarriers.
- To highlight strategies for overcoming current hurdles in therapeutic siRNA delivery.
Main Methods:
- Review of current literature on stimuli-sensitive nanoparticles for siRNA delivery.
- Analysis of various stimuli (acidic pH, enzymes, redox, magnetic fields) used in nanocarrier design.
- Discussion of multi-stimuli-responsive systems for enhanced therapeutic outcomes.
Main Results:
- Stimuli-sensitive nanocarriers can be designed to release siRNA in response to pathological microenvironments.
- Various stimuli-responsive mechanisms offer precise control over nucleic acid release at target sites.
- Combining multiple stimuli-responsive strategies presents a promising avenue for improved siRNA delivery efficacy.
Conclusions:
- Stimuli-sensitive nanopreparations represent a significant advancement in siRNA delivery for gene therapy.
- Targeted delivery using responsive nanocarriers can overcome key challenges in therapeutic siRNA application.
- Future research focusing on multi-stimuli-responsive systems could lead to more effective treatments for genetic diseases.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Site-Targeted

